Ahn DH, Barzi A, Ridinger M, Samuelsz E, et al. Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-line Treatment of KRAS-mutant Metastatic Colorectal Cancer: A Phase 1b Clinical Study. Clin Cancer Res 2024 Jan 17. doi: 10.1158/1078-0432.CCR-23-3053.
PMID: 38231047